Roche Holding AG (ROG.VX)

Swiss - Swiss Delayed Price. Currency in CHF
239.80-3.10 (-1.28%)
At close: 11:31 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close242.90
Bid240.60 x 243000
Ask241.80 x 260500
Day's Range239.10 - 243.90
52wk Range229.90 - 281.40
1y Target EstN/A
Market Cap204.35B
P/E Ratio (ttm)21.72
Avg Vol (3m)252,836
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Financial Timesyesterday

    [$$] Bristol-Myers Squibb misses mark with cancer drug

    Merck and Bristol-Myers Squibb have spent most of the past two years in a two-horse race to develop and sell immunotherapies, a new class of cancer drug that turns the body into a weapon against the disease.  ...

  • MarketWatch2 days ago

    European stocks book a loss as rate-hike signals intensify

    European stocks on Monday finish in negative territory, kicking off the week lower as rising expectations the U.S. Federal Reserve will lift interest rates later this year poke the air out of a recent ...

  • MarketWatch2 days ago

    FDA grants Roche Zika test emergency authorization

    Swiss drug maker Roche Holding AG said on Monday the U.S. Food and Drug Administration has issued an "emergency use authorization" for the its Zika test in another step to tackle the virus that ...